Kathryn White
Professor Cancer
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Kathryn White is a Professor of Cancer at the University of Sydney, Australia. Her research focuses on cancer survivorship, patient care pathways, and the development of educational interventions for healthcare professionals in oncology. Recent publications include studies on resilience in adults with cancer, interventions for improving communication with carers, and the impact of care models on patient outcomes. Professor White is dedicated to enhancing the quality of care for cancer patients through innovative research and evaluation.
Articles (18)
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Introduction Radiation therapy (RT) can benefit approximately 50% of cancer patients and contribute to 40% of all cancer cures, yet its utilisation in cancer is low globally. Several factors contribute to this including perceived inconvenience related to accessing and utilising RT. To quantitatively assess the latter, a new tool – the Radiation therapy‐related Inconvenience Questionnaire (RIQ) – was developed. This study aimed to pre‐test the RIQ and explore barriers and facilitators to implementing it in routine clinical practice and clinical trials. Methods Semi‐structured cognitive interviews were conducted with patients undertaking RT, recruited via three hospitals to examine content validity, acceptability, and comprehensibility of the RIQ. Interviews identified inconsistencies, relevance, and clarity of items. Semi‐structured interviews with healthcare professionals involved in the delivery of care to individuals undertaking RT explored barriers and facilitators to routine usage. Thematic analysis was used to identify themes. Results Patients ( N = 15) identified problems in content, instructions, layout, length, and response options; consequently, 25 items were revised and eight removed, resulting in a final 29‐item questionnaire. Clinicians identified staff‐ and patient‐specific barriers to implementing RIQ in clinical practice. Perceived facilitators included the following: (a) workplace factors, (b) mode of administration, and (c) imparting knowledge. Conclusion This study demonstrated acceptability and comprehensibility of the 29‐item RIQ amongst cancer patients undertaking RT and treating clinicians. The next phase will evaluate the RIQ's measurement properties in a larger clinical study. The barriers and facilitators identified can guide future implementation of RIQ in clinical practice and clinical trials.
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Year:
2020
Collaborators (14)
Penelope Schofield
Swinburne University of Technology
Judy Kay
Professor
University of Sydney
Christobel Saunders
University of Western Australia
Ian Olver
Adjunct Professor
University of Adelaide
Marguerite Tracy
Senior lecturer
University of Sydney
Puma Sundaresan
-
Philip Beale
-
Claudia Rutherford
-
Ilse Mesters
Associate professor
-
Judy M Simpson
Professor of Biostatistics
The University of Sydney School of Public Health
Sheena Arora
University of Sydney
Janani Mahadeva
Associate Professor
Macquarie University
Catherine Leahy
Charles Sturt University
Bryan Anthony Chan
Associate Professor
Griffith University
Make your next move.
Prepare your application
Review drafts before you send them.